Novavax COVID-19 Vaccine 89% Effective Against UK COVID-19 Strain
Biden’s Executive Order on Expanding Access to COVID-19 Therapies
Moderna Doses First Patient in Japanese Study of COVID-19 Vaccine
FDA Authorizes First Long-Acting Injectable for HIV Treatment
Thermo Fisher Inks $450M Deal to Acquire Mesa Biotech
Merck Terminates Development of COVID-19 Vaccine Candidates
Pfizer’s COVID-19 Vaccine Elicits Antibodies Against UK Strain
US to Remain WHO Member, Join Global COVID-19 Vaccine Program
Gilead, Vir Biotechnology to Evaluate Novel Therapies for HBV
COVID-19 Vaccine Dominates 2021 Pharmaceutical Industry Trends
Biden Executive Order Details New COVID-19 Response Plan
Janet Woodcock Acting FDA Commissioner After Hanh’s Departure
Experts Torn Over Half-Dosing Moderna, Pfizer COVID-19 Vaccines
Eli Lilly, Merus to Develop T-Cell Bispecific Antibody Therapies
HHS Expands Access to Buprenorphine for Opioid Use Disorder
Second COVID-19 Antibody from Vir, GSK Enters Phase 1b Trial
Switzerland Authorizes Moderna’s mRNA COVID-19 Vaccine
How Technology is Helping One Health System Distribute COVID-19 Vaccines
COVID-19, Vaccine Development Trends at JPM21
HHS Buys 1.25M More Doses of Regeneron’s COVID-19 Antibody Cocktail
Pfizer Invests $120M to Advance Biotechnology Innovation
Kaiser to Track Serious Adverse Events From COVID-19 Vaccination
HHS Distributes $22B to States for COVID-19 Testing, Vaccinations
NIH Initiates Trial to Evaluate COVID-19 Antibody Therapy
First Patient Treated in Study of Biogen’s Rare Disease Drug
EU Grants Emergency Use for Moderna’s mRNA COVID-19 Vaccine
Pfizer Kicks Off Phase 3 Trial for Rare Disease Gene Therapy
Kite, Oxford BioTherapeutics Partner to Research Cell Therapies
AstraZeneca’s COVID-19 Vaccine Gains Emergency Use in 6 Countries
Fujifilm to Invest $40M in Viral Vector Manufacturing Facility
FDA Approves First Generic Drug for Severe Hypoglycemia
FDA Warns Against Half-Dosing Pfizer, Moderna COVID-19 Vaccines
Moderna Ups COVID-19 Vaccine Manufacturing Estimate to 600M in 2021
UK Authorizes Emergency Use of AstraZeneca’s COVID-19 Vaccine
EU to Acquire Extra 100M Doses of Pfizer’s COVID-19 Vaccine
HHS Unveils 3-Part Plan for Supporting COVID-19 Testing Efforts